John Boylan
Stock Analyst at William Blair
(2.80)
# 1,575
Out of 5,182 analysts
8
Total ratings
100%
Success rate
21.74%
Average return
Main Sectors:
Stocks Rated by John Boylan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BBIO BridgeBio Pharma | Initiates: Outperform | n/a | $69.71 | - | 1 | Mar 10, 2026 | |
| CI The Cigna Group | Downgrades: Hold | n/a | $284.92 | - | 1 | Aug 18, 2023 | |
| GEHC GE HealthCare Technologies | Initiates: Hold | n/a | $68.50 | - | 1 | Jan 4, 2023 | |
| SYK Stryker | Upgrades: Buy | n/a | $321.43 | - | 1 | Jul 28, 2022 | |
| SYY Sysco | Upgrades: Buy | n/a | $73.37 | - | 2 | Sep 10, 2020 | |
| HSY The Hershey Company | Upgrades: Buy | n/a | $187.92 | - | 2 | Mar 25, 2020 |
BridgeBio Pharma
Mar 10, 2026
Initiates: Outperform
Price Target: n/a
Current: $69.71
Upside: -
The Cigna Group
Aug 18, 2023
Downgrades: Hold
Price Target: n/a
Current: $284.92
Upside: -
GE HealthCare Technologies
Jan 4, 2023
Initiates: Hold
Price Target: n/a
Current: $68.50
Upside: -
Stryker
Jul 28, 2022
Upgrades: Buy
Price Target: n/a
Current: $321.43
Upside: -
Sysco
Sep 10, 2020
Upgrades: Buy
Price Target: n/a
Current: $73.37
Upside: -
The Hershey Company
Mar 25, 2020
Upgrades: Buy
Price Target: n/a
Current: $187.92
Upside: -